Fangfang Tou

705 total citations
30 papers, 519 citations indexed

About

Fangfang Tou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fangfang Tou has authored 30 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fangfang Tou's work include Mitochondrial Function and Pathology (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Fangfang Tou is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Fangfang Tou collaborates with scholars based in China, Japan and United States. Fangfang Tou's co-authors include Zhi Zheng, Chang‐Ying Guo, Xiao‐Jian Han, Tao Wang, Xin-Hui Qu, Jun Rao, Xiaoming Wen, Hao Hu, Xi Liu and Liping Jiang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Fangfang Tou

30 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangfang Tou China 15 319 158 110 64 44 30 519
Jianlin Ren China 9 326 1.0× 115 0.7× 127 1.2× 42 0.7× 43 1.0× 18 578
Jichao Wei China 12 300 0.9× 179 1.1× 121 1.1× 65 1.0× 44 1.0× 22 557
Heran Wang China 11 388 1.2× 179 1.1× 187 1.7× 47 0.7× 48 1.1× 24 686
Jiao Xue China 11 333 1.0× 142 0.9× 83 0.8× 62 1.0× 31 0.7× 24 519
Sheeja Aravindan United States 15 298 0.9× 168 1.1× 146 1.3× 54 0.8× 50 1.1× 44 602
Shengchao Lin China 11 296 0.9× 201 1.3× 74 0.7× 69 1.1× 62 1.4× 12 497
Yuting Wu China 14 351 1.1× 131 0.8× 104 0.9× 113 1.8× 60 1.4× 30 567
Yong Han China 15 369 1.2× 245 1.6× 98 0.9× 84 1.3× 45 1.0× 53 683
Guoli Wei China 13 406 1.3× 266 1.7× 155 1.4× 61 1.0× 64 1.5× 46 717
Yung‐Lung Chang Taiwan 15 360 1.1× 104 0.7× 71 0.6× 51 0.8× 53 1.2× 32 566

Countries citing papers authored by Fangfang Tou

Since Specialization
Citations

This map shows the geographic impact of Fangfang Tou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Tou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Tou more than expected).

Fields of papers citing papers by Fangfang Tou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Tou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Tou. The network helps show where Fangfang Tou may publish in the future.

Co-authorship network of co-authors of Fangfang Tou

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Tou. A scholar is included among the top collaborators of Fangfang Tou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Tou. Fangfang Tou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Zhuo, Guifeng Sun, Zhen Zhang, et al.. (2024). Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167220–167220. 14 indexed citations
2.
Wang, Xing, Yuanyuan Liu, Xiao‐Jian Han, et al.. (2024). PILRB potentiates the PI3K/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis. Cell Death and Disease. 15(9). 642–642. 6 indexed citations
3.
Chen, Junjun, Tianzhu Lu, Tao Wang, et al.. (2024). The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway. Cell Death and Disease. 15(6). 390–390. 14 indexed citations
4.
Chen, Rui, et al.. (2024). A practical nomogram for predicting early death in elderly small cell lung cancer patients: A SEER-based study. Medicine. 103(17). e37759–e37759. 1 indexed citations
5.
Han, Xiaojian, et al.. (2024). PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. Breast Cancer Research. 26(1). 10–10. 12 indexed citations
6.
Wang, Tao, et al.. (2023). p32/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer. Acta Biochimica et Biophysica Sinica. 56(1). 34–43. 5 indexed citations
7.
Zhang, Kun, Tao Wang, Guifeng Sun, et al.. (2023). Metformin protects against retinal ischemia/reperfusion injury through AMPK-mediated mitochondrial fusion. Free Radical Biology and Medicine. 205. 47–61. 35 indexed citations
9.
Tou, Fangfang, et al.. (2022). Integrative analysis and identification of key elements and pathways regulated by Traditional Chinese Medicine (Yiqi Sanjie formula) in colorectal cancer. Frontiers in Pharmacology. 13. 1090599–1090599. 10 indexed citations
10.
Hua, Fang, Xin-Hui Qu, Shanshan Li, et al.. (2022). Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1. Molecular and Cellular Biochemistry. 478(7). 1519–1531. 17 indexed citations
11.
Wang, Tao, Xiaoyu Wang, Liping Jiang, et al.. (2022). Lactate protects against oxidative stress-induced retinal degeneration by activating autophagy. Free Radical Biology and Medicine. 194. 209–219. 21 indexed citations
12.
Xu, Dan, Kun Zhang, Xin-Hui Qu, et al.. (2022). Curcumin protects retinal neuronal cells against oxidative stress-induced damage by regulating mitochondrial dynamics. Experimental Eye Research. 224. 109239–109239. 8 indexed citations
13.
Rao, Jun, et al.. (2021). Molecular Characterization of Advanced Colorectal Cancer Using Serum Proteomics and Metabolomics. Frontiers in Molecular Biosciences. 8. 687229–687229. 23 indexed citations
14.
Zou, Yang, Rong Li, Meiling Zuo, et al.. (2020). Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA‐21 Expression. BioMed Research International. 2020(1). 5846938–5846938. 20 indexed citations
15.
Guo, Chang‐Ying, et al.. (2019). The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma. BMC Cancer. 19(1). 289–289. 24 indexed citations
16.
Zheng, Zhi, Zhiqiang Peng, Xinyi Chen, et al.. (2018). Metabolomics analysis of salvage chemotherapy on refractory acute myeloid leukemia patients. RSC Advances. 8(26). 14445–14453. 3 indexed citations
17.
Fan, Xing, Jun Rao, Ziwei Zhang, et al.. (2018). Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer. Cellular Physiology and Biochemistry. 46(4). 1317–1330. 11 indexed citations
18.
Zheng, Zhi, Shuofeng Zhang, Wuping Li, et al.. (2017). Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways. Oncotarget. 8(29). 47619–47631. 48 indexed citations
19.
Luo, Lan, Yoshishige Urata, Yan Chen, et al.. (2016). Radiation Exposure Decreases the Quantity and Quality of Cardiac Stem Cells in Mice. PLoS ONE. 11(5). e0152179–e0152179. 8 indexed citations
20.
Lyu, Qing, et al.. (2015). The natural product peiminine represses colorectal carcinoma tumor growth by inducing autophagic cell death. Biochemical and Biophysical Research Communications. 462(1). 38–45. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026